Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06697964

High Resolution Anuscopy Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Universitair Ziekenhuis Brussel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The majority of anal squamous cell carcinomas (SCC) stem from infection with high-risk human papillomavirus (HPV). Anal SCC is rare among the general population but affects several populations disproportionately. High-risk groups are screened through anal swabs for anal cytology and detection of high risk human papillomavirus (HR HPV). HRA referral is recommended for individuals with abnormal cytology. HRA represents the only method to identify precancerous lesions of the anal canal, with only few specialists knowledgeable about it. At UZ Brussel, the investigators collected a wealth of data about HPV infection and its association with anal pathology. By establishing a comprehensive study, the investigators can delve into this data with specific research questions, conducting valuable research to provide answers to pressing clinical questions and contribute to advancements in medical understanding and treatment.

Conditions

Interventions

TypeNameDescription
OTHERHRAHigh resolution anoscopy to help evaluate anal conditions such as precancerous lesions

Timeline

Start date
2024-08-08
Primary completion
2029-07-01
Completion
2029-07-01
First posted
2024-11-20
Last updated
2025-02-19

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT06697964. Inclusion in this directory is not an endorsement.